These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 20553604)

  • 1. Using serological measures to monitor changes in malaria transmission in Vanuatu.
    Cook J; Reid H; Iavro J; Kuwahata M; Taleo G; Clements A; McCarthy J; Vallely A; Drakeley C
    Malar J; 2010 Jun; 9():169. PubMed ID: 20553604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing malaria transmission in a low endemicity area of north-western Peru.
    Rosas-Aguirre A; Llanos-Cuentas A; Speybroeck N; Cook J; Contreras-Mancilla J; Soto V; Gamboa D; Pozo E; Ponce OJ; Pereira MO; Soares IS; Theisen M; D'Alessandro U; Erhart A
    Malar J; 2013 Sep; 12():339. PubMed ID: 24053144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sparse serological evidence of Plasmodium vivax transmission in the Ouest and Sud-Est departments of Haiti.
    Weppelmann TA; von Fricken ME; Lam B; Telisma T; Existe A; Lemoine JF; Larkin J; Okech BA
    Acta Trop; 2016 Oct; 162():27-34. PubMed ID: 27230796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia.
    Cook J; Speybroeck N; Sochanta T; Somony H; Sokny M; Claes F; Lemmens K; Theisen M; Soares IS; D'Alessandro U; Coosemans M; Erhart A
    Malar J; 2012 Mar; 11():86. PubMed ID: 22443375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009.
    Wong J; Hamel MJ; Drakeley CJ; Kariuki S; Shi YP; Lal AA; Nahlen BL; Bloland PB; Lindblade KA; Were V; Otieno K; Otieno P; Odero C; Slutsker L; Vulule JM; Gimnig JE
    Malar J; 2014 Nov; 13():451. PubMed ID: 25416454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of serological data to investigate heterogeneity of malaria transmission: a community-based cross-sectional study in an area conducting elimination in Indonesia.
    Surendra H; Wijayanti MA; Murhandarwati EH; Irnawati ; Yuniarti T; Mardiati ; Herdiana ; Sumiwi ME; Hawley WA; Lobo NF; Cook J; Drakeley C; Supargiyono
    Malar J; 2019 Jul; 18(1):227. PubMed ID: 31286973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting.
    Dewasurendra RL; Dias JN; Sepulveda N; Gunawardena GS; Chandrasekharan N; Drakeley C; Karunaweera ND
    BMC Infect Dis; 2017 Jan; 17(1):49. PubMed ID: 28068925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific malaria seroprevalence rates: a cross-sectional analysis of malaria transmission in the Ouest and Sud-Est departments of Haiti.
    von Fricken ME; Weppelmann TA; Lam B; Eaton WT; Schick L; Masse R; Beau De Rochars MV; Existe A; Larkin J; Okech BA
    Malar J; 2014 Sep; 13():361. PubMed ID: 25218803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological measures to assess the efficacy of malaria control programme on Ambae Island, Vanuatu.
    Idris ZM; Chan CW; Mohammed M; Kalkoa M; Taleo G; Junker K; Arcà B; Drakeley C; Kaneko A
    Parasit Vectors; 2017 Apr; 10(1):204. PubMed ID: 28441959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geostatistical modeling of malaria endemicity using serological indicators of exposure collected through school surveys.
    Ashton RA; Kefyalew T; Rand A; Sime H; Assefa A; Mekasha A; Edosa W; Tesfaye G; Cano J; Teka H; Reithinger R; Pullan RL; Drakeley CJ; Brooker SJ
    Am J Trop Med Hyg; 2015 Jul; 93(1):168-177. PubMed ID: 25962770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-malarial seroprevalence assessment during an elimination programme in Chabahar District, south-eastern Iran.
    Zakeri S; van den Hoogen LL; Mehrizi AA; Karimi F; Raeisi A; Drakeley C
    Malar J; 2016 Jul; 15(1):382. PubMed ID: 27448606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographical patterns of malaria transmission based on serological markers for falciparum and vivax malaria in Ratanakiri, Cambodia.
    Kerkhof K; Sluydts V; Heng S; Kim S; Pareyn M; Willen L; Canier L; Sovannaroth S; Ménard D; Sochantha T; Coosemans M; Durnez L
    Malar J; 2016 Oct; 15(1):510. PubMed ID: 27756395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia.
    Supargiyono S; Bretscher MT; Wijayanti MA; Sutanto I; Nugraheni D; Rozqie R; Kosasih AA; Sulistyawati S; Hawley WA; Lobo NF; Cook J; Drakeley CJ
    Malar J; 2013 Dec; 12():444. PubMed ID: 24321092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologically defined variations in malaria endemicity in Pará state, Brazil.
    Cunha MG; Silva ES; Sepúlveda N; Costa SP; Saboia TC; Guerreiro JF; Póvoa MM; Corran PH; Riley E; Drakeley CJ
    PLoS One; 2014; 9(11):e113357. PubMed ID: 25419900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium vivax and Plasmodium falciparum infections in the Republic of Djibouti: evaluation of their prevalence and potential determinants.
    Khaireh BA; Briolant S; Pascual A; Mokrane M; Machault V; Travaillé C; Khaireh MA; Farah IH; Ali HM; Abdi AI; Ayeh SN; Darar HY; Ollivier L; Waiss MK; Bogreau H; Rogier C; Pradines B
    Malar J; 2012 Nov; 11():395. PubMed ID: 23190709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-epitope chimeric antigen used as a serological marker to estimate Plasmodium falciparum transmission intensity in the border area of China-Myanmar.
    Yao MX; Sun XD; Gao YH; Cheng ZB; Deng WW; Zhang JJ; Wang H
    Infect Dis Poverty; 2016 Sep; 5(1):98. PubMed ID: 27604628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
    Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
    Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.
    Ramasamy R; Nagendran K; Ramasamy MS
    Am J Trop Med Hyg; 1994 May; 50(5):537-47. PubMed ID: 7515593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
    Soares IS; Oliveira SG; Souza JM; Rodrigues MM
    Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname.
    Labadie-Bracho MY; van Genderen FT; Adhin MR
    Malar J; 2020 Oct; 19(1):360. PubMed ID: 33032606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.